Evidence map›Paper›PMID 32907987›Full record

ArticleJournal of lipid research2020

Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood.

Ryunosuke Ohkawa, Hann Low, Nigora Mukhamedova, Ying Fu, Shao-Jui Lai, Mai Sasaoka, Ayuko Hara, Azusa Yamazaki, Takahiro Kameda, Yuna Horiuchi and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Cholesterol in the Cell Membrane-An Emerging Player in Atherogenesis.International journal of molecular sciences · 2022
    Review
  19. The role of cholesterol in invasion and growth of malaria parasites.Frontiers in cellular and infection microbiology · 2022
    Review
  20. High Free Cholesterol Bioavailability Drives the Tissue Pathologies in Scarb1Arteriosclerosis, thrombosis, and vascular biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 3 countries.

Ryunosuke OhkawaDepartment of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan; Baker Heart and Diabetes Institute, Melbourne, Australia. Electronic address: ohkawa.alc@tmd.ac.jp.
Hann LowBaker Heart and Diabetes Institute, Melbourne, Australia.
Nigora MukhamedovaBaker Heart and Diabetes Institute, Melbourne, Australia.
Ying FuBaker Heart and Diabetes Institute, Melbourne, Australia.
Shao-Jui LaiDepartment of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Mai SasaokaDepartment of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Ayuko HaraDepartment of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Azusa YamazakiDepartment of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Takahiro KamedaDepartment of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Yuna HoriuchiDepartment of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Peter J MeikleBaker Heart and Diabetes Institute, Melbourne, Australia.
Gerard PernesBaker Heart and Diabetes Institute, Melbourne, Australia.
Graeme LancasterBaker Heart and Diabetes Institute, Melbourne, Australia.
Michael DitiatkovskiBaker Heart and Diabetes Institute, Melbourne, Australia.
Paul NestelBaker Heart and Diabetes Institute, Melbourne, Australia.
Boris VaismanLipoprotein Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Denis SviridovLipoprotein Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Andrew MurphyBaker Heart and Diabetes Institute, Melbourne, Australia.
Alan T RemaleyLipoprotein Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Dmitri SviridovBaker Heart and Diabetes Institute, Melbourne, Australia; Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia. Electronic address: Dmitri.Sviridov@baker.edu.au.
Minoru TozukaDepartment of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan; Life Science Research Center, Nagano Children's Hospital, Azumino, Japan.
Baker Heart and Diabetes Institute · AUTokyo Medical and Dental University · JPNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipoproteins play a key role in transport of cholesterol to and from tissues. Recent studies have also demonstrated that red blood cells (RBCs), which carry large quantities of free cholesterol in their membrane, play an important role in reverse cholesterol transport. However, the exact role of RBCs in systemic cholesterol metabolism is poorly understood. RBCs were incubated with autologous plasma or isolated lipoproteins resulting in a significant net amount of cholesterol moved from RBCs to HDL, while cholesterol from LDL moved in the opposite direction. Furthermore, the bi-directional cholesterol transport between RBCs and plasma lipoproteins was saturable and temperature-, energy-, and time-dependent, consistent with an active process. We did not find LDLR, ABCG1, or scavenger receptor class B type 1 in RBCs but found a substantial amount of ABCA1 mRNA and protein. However, specific cholesterol efflux from RBCs to isolated apoA-I was negligible, and ABCA1 silencing with siRNA or inhibition with vanadate and Probucol did not inhibit the efflux to apoA-I, HDL, or plasma. Cholesterol efflux from and cholesterol uptake by RBCs from

Indexed as

ATP Binding Cassette Transporter 1CholesterolErythrocytesAnimalsBiological TransportHumansLipoproteinsMaleMiceMice, Inbred C57BLATP Binding Cassette Transporter 1CholesterolLipoproteinsadenosine 5′-triphosphate binding cassette transporter A1apolipoprotein A-Icholesterol fluxcholesterol/metabolismerythrocytehigh density lipoproteinlipidomicslow density lipoprotein

Identifiers

PMID32907987
PMCPMC7707172
OpenAlexW3084341481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.